Con Salud – Marañón Develops a Pioneering Cell Therapy to Prevent Transplant Rejection
The treatment uses thymus-derived regulatory T cells (Treg) to regulate the immune system’s response and prevent rejection. Researchers at Hospital General Universitario Gregorio Marañón have developed a world-pioneering therapy to prevent immune rejection in organ transplantation. The approach is based on thyTreg cells, as explained by the hospital. Over six years, the hospital’s Immunoregulation Laboratory, […]
Vivir Ediciones – The Community of Madrid Develops at Gregorio Marañón Hospital a World-Pioneering Cell Therapy to Prevent Transplant Rejection
Three babies who have undergone heart transplants are already being treated with this technique and are progressing favorably. Researchers at Hospital General Universitario Gregorio Marañón, part of the public hospital network of the Community of Madrid, have independently developed a world-unique treatment to prevent immune rejection and potentially extend indefinitely the survival of transplanted organs […]
Gacetín Madrid – Madrid Develops a World-Pioneering Treatment to Prevent Transplant Rejection
Researchers at Hospital General Universitario Gregorio Marañón, part of the public hospital network of the Community of Madrid, have independently developed a world-unique treatment to prevent immune rejection and potentially extend indefinitely the survival of transplanted organs — and therefore the lives of patients. The team from the hospital’s Immunoregulation Laboratory, responsible for this pioneering […]
El Imparcial – Marañón Develops a Pioneering Technique to Prevent Organ Transplant Rejection
Most transplanted organs last fewer than 20 years and, therefore, are not lifelong solutions. In an effort to extend graft survival, Hospital General Universitario Gregorio Marañón has conducted research that has yielded promising results. To make transplanted organs last a lifetime, a team at the Madrid hospital has developed a new therapy aimed at reducing […]
Diario Médico – A Baby Receives Cell Therapy for the First Time in the World to Prevent Graft Rejection
Thymus-Derived Cell Therapy Prevents Transplanted Organ Rejection and Reduces Immunosuppression Requirements. More info: diariomedico.com
servimedia – Cell Therapy Developed to Prevent Organ Transplant Rejection
Researchers at Hospital General Universitario Gregorio Marañón have developed a world-pioneering cell-based therapy to prevent immune rejection in organ transplantation and potentially extend indefinitely the survival of transplanted organs — and therefore the lives of patients. Three infants are already being treated at the hospital. The therapy and underlying technology were developed by the hospital’s […]
El Correo – A Spanish Therapy Opens the Door to Lifelong Transplants
Hospital General Universitario Gregorio Marañón has developed a cell-based treatment that prevents organ rejection without causing side effects, as it does not rely on immunosuppressive drugs. Irene Toribios González was born six months ago at the Madrid hospital with a congenital heart defect incompatible with life, requiring an urgent heart transplant. Under normal circumstances, after […]
ABC – Irene, the First Child to Receive a Pioneering Cell Therapy to Prevent Transplant Rejection
Researchers at Hospital General Universitario Gregorio Marañón have developed a world-pioneering cell-based treatment to prevent organ transplant rejection. The therapy may regulate the immune system’s response and prevent rejection, and three patients are already being treated with this approach. Its goal is to extend indefinitely the survival of the transplanted organ and the patient’s life. […]
La razón – Closer to a Lifelong Transplant
Researchers at Hospital General Universitario Gregorio Marañón have developed a cell-based therapy to prevent transplant rejection by administering regulatory cells derived from the patient’s own thymic tissue. “I was surprised when they told me that transplants are not for life,” says Irene’s father. Irene was born with cardiomyopathy and underwent a heart transplant last November. […]
Redacción Médica – Marañón Makes History: First Cell Therapy for Transplant Rejection
Researchers at Hospital General Universitario Gregorio Marañón have developed a treatment based on regulatory T cells extracted from thymic tissue — the thymus — marking a potential turning point in transplant medicine. Preventing rejection and extending the survival of transplanted organs through cell therapy was once considered unthinkable. However, after seven years of research, the […]
